The Effect of Doxorubicin on Viability and Morphology of Human Embryonic Stem Cell-derived Cardiomyocytes

Subject Areas : Journal of Chemical Health Risks

Marziyeh Shalchi Tousi ¹ , Houri Sepehri ²

1 - Department of Animal Physiology, College of Science, University of Tehran, Tehran, Iran
2 - Department of Animal Physiology, College of Science, University of Tehran, Tehran, Iran

Received: 2014-08-23 Accepted : 2018-10-29 Published : 2018-10-29

Keywords:

References:

1. Blum R., Carter S., 1974. Adriamycin: A New Anticancer Drug with Significant Clinical Activity. Ann Intern Med. 80: 249ââ‚‌“259.
2. Xua M.F., Tangb P.L., Qianb Z.M., Ashraf M., 2001. Effects by doxorubicin on the myocardium are mediated by oxygen free radicals. Life Sci. 68: 889ââ‚‌“901.
3. Granados S., Quiles J.L., Ramirez-Tortosa C.L., Sanchez-Rovira P., Ramirez-Tortosa M.C., 2010. New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol. 48: 1425ââ‚‌“38.
4. Minotti G., Menna P., Salvatorelli E., Cairo G., Gianni L., 2004. Anthracyclines : Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol Rev. 56: 185ââ‚‌“229.
5. Zeevi N., Itskovitz-Eldor J., Binah O., 2012. Cardiomyocytes derived from human pluripotent stem cells for drug screening. Pharmacol Ther. 134: 180ââ‚‌“188.
6. Denning C., Anderson D., 2008. Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity. Drug Discovery Today: Therapeutic Strategies. 5: 223ââ‚‌“232.
7. Thomson J.A., Waknitz M.A., Swiergiel J.J., Marshall V.S., 1998. Embryonic Stem Cell Lines Derived from Human Blastocysts. Science. 282: 1145ââ‚‌“1147.
8. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomodo K., Yamanaka S., 2007. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell. 131: 861ââ‚‌“872.
9. Kehat I., Kenyagin-karsenti D., Snir M., Segev H., Amit M., Gepstein A., Livne E., Binah, O., Itskovitz-eldor J., Gepstein L., 2001. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest. 108: 363ââ‚‌“364.
10. Sartipy P., Bjorquist P., 2011. Concise Review: Human Pluripotent Stem Cell-Based Models for Cardiac and Hepatic Toxicity Assessment. Stem Cell. 29: 744ââ‚‌“748.
11. Vidarsson H., Hyllner J., Sartipy P., 2010. Differentiation of Human Embryonic Stem Cells to Cardiomyocytes for In Vitro and In Vivo Applications. Stem Cell Reviews and Reports. 6: 108ââ‚‌“120.
12. Baharvand H., Kazemi Ashtiani S., Taee A., Massumi M., Valojerdi M., Yazdi P., Moradi S., Farrokhi A., 2006. Generation of new human embryonic stem cell lines with diploid and triploid karyotypes. Dev. Growth Differ. 48: 117ââ‚‌“128.
13. Rezaei Larijani M., Seifinejad A., Pournasr B., Hajihoseini V., Hasani N., Baharvand H., 2011. Long-term Maintenance of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells in Suspension. Stem Cells Dev. 20: 1911ââ‚‌“1923.
14. Gonzalez R., Lee J.W., Schultz P.G., 2011. Stepwise Chemically Induced Cardiomyocyte Specification of Human Embryonic Stem Cells. Angew. Chem Int Ed. 2:11181ââ‚‌“11185.
15. Rajamohan D., Matsa E., Kalra S., Crutchley J., Patel A., George V., à C.D., 2013. Prospects & Overviews Current status of drug screening and disease modelling in human pluripotent stem cells. BioEssays. 35: 281ââ‚‌“298.
16. Brito-Martins M., Harding S., 2008. beta (1)- and beta (2)-adrenoceptor responses in cardiomyocytes derived from human embryonic stem cells: comparison with failing and non-failing adult human heart. Br J Pharmacol. 153: 751ââ‚‌“759.
17. Mummery C.L., Zhang J., Ng E.S., Elliott, D.A., Elefanty A.G., Kamp T.J., 2012. Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells to Cardiomyocytes A Methods Overview CM. Circulation Res. 111: 344ââ‚‌“358.
18. Sadek H., Hannack B., Choe E., Wang J., Latif S., Garry M.G., Garry D.J., Longgood J., Frantz D.E., Olson E.N., Hsieh J., Schneider J.W., 2008. Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc Natl Acad Sci USA. 105: 6063- 6068.